AR
TMO icon

Apeiron RIA’s Thermo Fisher Scientific TMO Stock Holding History

Apeiron RIA’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-791
Closed -$321K – 226
2025
Q2 		$321K Sell
791
-137
-15% -$57.3K 0.08% 163
2025
Q1 		$462K Sell
928
-11
-1% -$5.96K 0.14% 130
2024
Q4 		$489K Buy
939
+171
+22% +$94K 0.14% 122
2024
Q3 		$475K Buy
768
+11
+1% +$6.51K 0.14% 120
2024
Q2 		$418K Sell
757
-15
-2% -$8.59K 0.13% 131
2024
Q1 		$449K Sell
772
-6
-0.8% -$3.37K 0.13% 128
2023
Q4 		$413K Buy
778
+107
+16% +$51.8K 0.13% 127
2023
Q3 		$340K Buy
671
+31
+5% +$16.5K 0.12% 142
2023
Q2 		$334K Sell
640
-23
-3% -$12.4K 0.11% 138
2023
Q1 		$382K Buy
663
+15
+2% +$8.45K 0.13% 113
2022
Q4 		$357K Buy
648
+7
+1% +$3.71K 0.14% 115
2022
Q3 		$321K Buy
+641
New +$359K 0.15% 115
2022
Q2 		– Sell
-516
Closed -$316K – 198
2022
Q1 		$316K Buy
516
+41
+9% +$23.6K 0.15% 110
2021
Q4 		$317K Buy
+475
New +$297K 0.13% 113

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Apeiron RIA's TMO Position: Q3 2025 in Review

Apeiron RIA sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 791 shares — an estimated $321K sold.

Apeiron RIA first reported a position in TMO in Q4 2021 and held it in 14 quarters. The position peaked at $489K in Q4 2024. 2,515 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Apeiron RIA reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Apeiron RIA sold 791 Thermo Fisher Scientific shares in Q3 2025, an estimated $321K.
  • Apeiron RIA first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 14 quarters.
  • Apeiron RIA's Thermo Fisher Scientific position peaked at $489K in Q4 2024.
  • 2,515 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Apeiron RIA's 13F filing for Q3 2025, filed 14 Oct 2025.